recruitment vendors

R&D

Patient recruitment remains a significant challenge for biopharma companies, often leading to delays and increased costs in clinical trials.

News

Pressure is building on Amgen to withdraw rare disease therapy Tavneos, after the CHMP recommended its marketing authorisation by revoked in the EU.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.